KLWA
Kelly Lawrence W & Associates Portfolio holdings
AUM
$382M
This Quarter Return
+8.69%
1 Year Return
+13.86%
3 Year Return
+61.56%
5 Year Return
+124.1%
10 Year Return
+368.26%
AUM
$369M
AUM Growth
+$369M
(+5.2%)
Cap. Flow
-$6.39M
Cap. Flow
% of AUM
-1.73%
Top 10 Holdings %
Top 10 Hldgs %
45.57%
Holding
168
New
3
Increased
14
Reduced
34
Closed
2
Top Buys
| 1 |
American Tower
AMT
|
$368K |
| 2 |
Eli Lilly
LLY
|
$257K |
| 3 |
Intel
INTC
|
$183K |
| 4 |
Medtronic
MDT
|
$173K |
| 5 |
Gilead Sciences
GILD
|
$170K |
Top Sells
| 1 |
Apple
AAPL
|
$1.06M |
| 2 |
Visa
V
|
$436K |
| 3 |
Roper Technologies
ROP
|
$344K |
| 4 |
IQVIA
IQV
|
$266K |
| 5 |
Albemarle
ALB
|
$265K |
Sector Composition
| 1 | Technology | 31.9% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.95% |
| 4 | Communication Services | 11.09% |
| 5 | Consumer Staples | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Procter & Gamble
PG
$368B
| $4.08M | 1.11% |
27,439
+230
| +0.8% | +$34.2K |
|
27
Cisco
CSCO
$274B
| $3.88M | 1.05% |
74,252
| – | – |
|
28
Chevron
CVX
$324B
| $3.68M | 1% |
22,552
+35
| +0.2% | +$5.71K |
|
29
Aflac
AFL
$57.2B
| $3.63M | 0.98% |
56,290
-800
| -1% | -$51.6K |
|
30
Hexcel
HXL
$5.02B
| $3.16M | 0.86% |
46,275
-80
| -0.2% | -$5.46K |
|
31
Microsoft
MSFT
$3.77T
| $2.64M | 0.72% |
9,155
| – | – |
|
32
Salesforce
CRM
$245B
| $2.22M | 0.6% |
11,125
| – | – |
|
33
Woodward
WWD
$14.8B
| $2.15M | 0.58% |
22,080
-475
| -2% | -$46.3K |
|
34
AbbVie
ABBV
$372B
| $2.11M | 0.57% |
13,218
| – | – |
|
35
Rithm Capital Corp. 7.125% Series B Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock
RITM.PRB
$284M
| $1.63M | 0.44% |
76,883
| – | – |
|
36
JPMorgan Chase
JPM
$829B
| $1.62M | 0.44% |
12,460
-40
| -0.3% | -$5.21K |
|
37
WELLS FARGO 7.5% NON CUMV PERP CONV
WFC.PRL
$4.82B
| $1.31M | 0.35% |
1,134
| – | – |
|
38
Shell
SHEL
$215B
| $1.29M | 0.35% |
22,456
| – | – |
|
39
VeriSign
VRSN
$25.5B
| $1.27M | 0.34% |
5,995
| – | – |
|
40
Edwards Lifesciences
EW
$47.8B
| $1.16M | 0.31% |
14,040
-885
| -6% | -$73.2K |
|
|
41
Gilead Sciences
GILD
$140B
| $990K | 0.27% |
11,931
+2,050
| +21% | +$170K |
|
42
Dow Inc
DOW
$17.5B
| $973K | 0.26% |
17,747
+2,200
| +14% | +$121K |
|
43
Charles Schwab
SCHW
$174B
| $894K | 0.24% |
17,068
| – | – |
|
44
McDonald's
MCD
$224B
| $733K | 0.2% |
2,622
+397
| +18% | +$111K |
|
45
Pfizer
PFE
$141B
| $719K | 0.19% |
17,623
| – | – |
|
46
AGNC Investment Dep Shares 1/1000 Cumulative Series E
AGNCO
| $695K | 0.19% |
34,367
| – | – |
|
47
AT&T Series A
T.PRA
$985M
| $674K | 0.18% |
30,200
+2,100
| +7% | +$46.9K |
|
48
Avery Dennison
AVY
$13.4B
| $644K | 0.17% |
3,600
-100
| -3% | -$17.9K |
|
49
Abbott
ABT
$231B
| $614K | 0.17% |
6,060
| – | – |
|
50
Verizon
VZ
$186B
| $612K | 0.17% |
15,745
| – | – |
|